Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Department of Chemistry, The University of Texas at Austin, Austin, TX 78712.
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7160-7165. doi: 10.1073/pnas.1705154114. Epub 2017 May 30.
The σ receptor is an enigmatic protein that has attracted significant attention because of its involvement in diseases as diverse as cancer and neurological disorders. Unlike virtually all other receptors of medical interest, it has eluded molecular cloning since its discovery, and the gene that codes for the receptor remains unknown, precluding the use of modern biological methods to study its function. Using a chemical biology approach, we purified the σ receptor from tissue, revealing its identity as TMEM97, an endoplasmic reticulum-resident transmembrane protein that regulates the sterol transporter NPC1. We show that TMEM97 possesses the full suite of molecular properties that define the σ receptor, and we identify Asp29 and Asp56 as essential for ligand recognition. Cloning the σ receptor resolves a longstanding mystery and will enable therapeutic targeting of this potential drug target.
σ 受体是一种神秘的蛋白质,由于其与癌症和神经紊乱等多种疾病有关,因此引起了广泛关注。与几乎所有其他具有医学意义的受体不同,自从发现以来,它一直无法通过分子克隆进行克隆,编码受体的基因仍然未知,这使得无法使用现代生物学方法来研究其功能。我们使用化学生物学方法从组织中纯化了 σ 受体,揭示了其作为 TMEM97 的身份,这是一种内质网驻留的跨膜蛋白,可调节固醇转运蛋白 NPC1。我们表明,TMEM97 具有定义 σ 受体的全套分子特性,并且我们确定 Asp29 和 Asp56 对配体识别至关重要。克隆 σ 受体解决了一个长期存在的谜团,并将使针对该潜在药物靶标的治疗成为可能。